The reaction online by new users of Mirvaso, you would have to say, has not been good. The reports of rebound flushing, that is; worse flushing after using Mirvaso compared to before, far outweigh happy users.
From those users who have posted online at the various Mirvaso threads, the trend for adverse reactions appears to be much higher than experienced by the large Phase 3 Mirvaso clinical trials. Rebound flushing from Mirvaso has even attracted a newspaper article on the topic.
For example, going by the clinical trial results quoted in the Mirvaso Prescribing Information one could expect to have adversely increased flushing in about 10% of users and increased redness in about 8% of users. As mentioned, online reports appear to be much higher than this.
Officially Mirvaso is for the treatment of the non-transient i.e. permanent red face of rosacea, but published results from adverse reactions show that it can increase flushing, redness, burning, dermatitis, acne in some users. For more details see Will I have a Bad Reaction to Mirvaso?
What Should I do?
If you are experiencing worsening of your facial redness, and you feel that it is because of a reaction to Mirvaso, you can report it as an adverse event to Galderma and to the FDA.
The Mirvaso Prescribing Information has a short note about what to do if you have a bad reaction after using it.
To report SUSPECTED ADVERSE REACTIONS, contact Galderma Laboratories, L.P. at 1-866-735-4137 or
FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
It appears that you can click through to a voluntary reporting form here;
where you can add details of your bad experience with Mirvaso.
Users who have contacted Galderma have reported success in obtaining a refund for their purchase.
Please let us know
If you do officially file an adverse event report, please let us know if you hear anything back from the FDA or Galderma.